Sharada Mokkapati

1.0k total citations
32 papers, 686 citations indexed

About

Sharada Mokkapati is a scholar working on Surgery, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Sharada Mokkapati has authored 32 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 14 papers in Molecular Biology and 7 papers in Immunology and Allergy. Recurrent topics in Sharada Mokkapati's work include Bladder and Urothelial Cancer Treatments (14 papers), Cell Adhesion Molecules Research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sharada Mokkapati is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Cell Adhesion Molecules Research (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Sharada Mokkapati collaborates with scholars based in United States, United Kingdom and Germany. Sharada Mokkapati's co-authors include Roswitha Nischt, Neil Smyth, Anke Baranowsky, Nicolai Miosge, Monzur Murshed, B. Bader, Sabine Nedbal, Matthew Ho, Le Huang and Dirk Breitkreutz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sharada Mokkapati

30 papers receiving 673 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharada Mokkapati United States 14 278 180 160 105 93 32 686
Hanneke N. Monsuur Netherlands 12 273 1.0× 141 0.8× 115 0.7× 115 1.1× 40 0.4× 17 635
Pamma D. Arora Canada 17 363 1.3× 230 1.3× 384 2.4× 105 1.0× 64 0.7× 23 920
Martin Degen Switzerland 17 480 1.7× 230 1.3× 263 1.6× 154 1.5× 74 0.8× 36 954
Dorothy A. Beacham United States 11 236 0.8× 198 1.1× 185 1.2× 195 1.9× 95 1.0× 14 683
Olena Jacenko United States 20 476 1.7× 254 1.4× 178 1.1× 114 1.1× 81 0.9× 35 1.1k
Minlong Shi China 7 549 2.0× 213 1.2× 132 0.8× 200 1.9× 95 1.0× 7 1.1k
Francesco J. Conti United Kingdom 9 340 1.2× 241 1.3× 249 1.6× 123 1.2× 46 0.5× 9 730
Kenneth Dickerson United States 7 374 1.3× 130 0.7× 137 0.9× 59 0.6× 47 0.5× 8 718
Daniela Zwolanek Germany 11 255 0.9× 117 0.7× 125 0.8× 45 0.4× 89 1.0× 13 609
Caroline Hutter Austria 15 363 1.3× 116 0.6× 178 1.1× 211 2.0× 136 1.5× 32 1.2k

Countries citing papers authored by Sharada Mokkapati

Since Specialization
Citations

This map shows the geographic impact of Sharada Mokkapati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharada Mokkapati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharada Mokkapati more than expected).

Fields of papers citing papers by Sharada Mokkapati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharada Mokkapati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharada Mokkapati. The network helps show where Sharada Mokkapati may publish in the future.

Co-authorship network of co-authors of Sharada Mokkapati

This figure shows the co-authorship network connecting the top 25 collaborators of Sharada Mokkapati. A scholar is included among the top collaborators of Sharada Mokkapati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharada Mokkapati. Sharada Mokkapati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mokkapati, Sharada, Ganiraju C. Manyam, Alberto Martini, et al.. (2025). Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.. Translational Oncology. 52. 102269–102269. 1 indexed citations
3.
Mokkapati, Sharada, et al.. (2024). The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward. Bladder Cancer. 10(2). 105–112. 2 indexed citations
4.
Martini, Alberto, Ganiraju C. Manyam, Yan Chen, et al.. (2024). Single-cell RNA sequencing analysis identifies acute changes in the tumor microenvironment induced by interferon α gene therapy in a murine bladder cancer model. Frontiers in Immunology. 15. 1387229–1387229. 2 indexed citations
5.
6.
Narayan, Vikram M., Sharada Mokkapati, Alberto Martini, et al.. (2024). Urinary minimal residual disease detection predicts recurrence in BCG-unresponsive NIMBC and quantifies molecular response to nadofaragene firadenovec.. Journal of Clinical Oncology. 42(4_suppl). 635–635.
7.
Martini, Alberto, et al.. (2023). The current status of gene therapy in bladder cancer. Expert Review of Anticancer Therapy. 23(5). 531–543. 9 indexed citations
8.
Mitra, Anirban P., Sharada Mokkapati, Tanner Miest, et al.. (2022). MP54-05 EVALUATING INTRAVESICAL NADOFARAGENE FIRADENOVEC AND IMMUNE CHECKPOINT BLOCKADE COMBINATION THERAPY IN BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: EVIDENCE FROM A PHASE 3 TRIAL. The Journal of Urology. 207(Supplement 5). 1 indexed citations
9.
Mokkapati, Sharada, Sima P. Porten, Vikram M. Narayan, et al.. (2020). TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer. Molecular Cancer Research. 18(6). 811–821. 6 indexed citations
10.
Choi, Woonyoung, Sharada Mokkapati, Debasish Sundi, et al.. (2019). Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation. OncoImmunology. 8(5). e1577125–e1577125. 10 indexed citations
11.
Mokkapati, Sharada, Vikram M. Narayan, Michael Metcalfe, et al.. (2019). Lentiviral interferon: A novel method for gene therapy in bladder cancer.. Journal of Clinical Oncology. 37(7_suppl). 456–456. 1 indexed citations
12.
Mokkapati, Sharada, Kimberly S. Schluns, David J. McConkey, et al.. (2018). The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside. World Journal of Urology. 37(10). 2041–2049. 20 indexed citations
13.
Huang, Le, Sharada Mokkapati, Qianghua Hu, et al.. (2016). Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation. Neoplasia. 18(2). 71–81. 20 indexed citations
14.
Mokkapati, Sharada, Le Huang, E. Cristy Ruteshouser, et al.. (2014). β-Catenin Activation in a Novel Liver Progenitor Cell Type Is Sufficient to Cause Hepatocellular Carcinoma and Hepatoblastoma. Cancer Research. 74(16). 4515–4525. 72 indexed citations
15.
Frie, Christian, et al.. (2012). Epidermal Transglutaminase (TGase 3) Is Required for Proper Hair Development, but Not the Formation of the Epidermal Barrier. PLoS ONE. 7(4). e34252–e34252. 37 indexed citations
16.
Mokkapati, Sharada, et al.. (2012). Absence of the Basement Membrane Component Nidogen 2, but Not of Nidogen 1, Results in Increased Lung Metastasis in Mice. Journal of Histochemistry & Cytochemistry. 60(4). 280–289. 20 indexed citations
17.
Mokkapati, Sharada, Manuel Koch, Dirk Breitkreutz, et al.. (2010). Basement Membrane Deposition of Nidogen 1 but Not Nidogen 2 Requires the Nidogen Binding Module of the Laminin γ1 Chain. Journal of Biological Chemistry. 286(3). 1911–1918. 14 indexed citations
18.
Baranowsky, Anke, Sharada Mokkapati, Nicolai Miosge, et al.. (2009). Impaired wound healing in mice lacking the basement membrane protein nidogen 1. Matrix Biology. 29(1). 15–21. 31 indexed citations
19.
Ho, Matthew, et al.. (2008). Nidogens—Extracellular matrix linker molecules. Microscopy Research and Technique. 71(5). 387–395. 95 indexed citations
20.
Nischt, Roswitha, Nicolae Mirancea, Anke Baranowsky, et al.. (2006). Lack of Nidogen-1 and -2 Prevents Basement Membrane Assembly in Skin-Organotypic Coculture. Journal of Investigative Dermatology. 127(3). 545–554. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanneke N. Monsuur Breakdown of academic impact, for papers by Pamma D. Arora Breakdown of academic impact, for papers by Martin Degen Breakdown of academic impact, for papers by Dorothy A. Beacham Breakdown of academic impact, for papers by Olena Jacenko Breakdown of academic impact, for papers by Minlong Shi Breakdown of academic impact, for papers by Francesco J. Conti Breakdown of academic impact, for papers by Kenneth Dickerson Breakdown of academic impact, for papers by Daniela Zwolanek Breakdown of academic impact, for papers by Caroline Hutter
Rankless by CCL
2026